Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | atractyloside | 2353 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | atractyloside | 2353 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | flurbiprofen | 3394 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | flurbiprofen | 3394 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | flurbiprofen | 3394 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | flurbiprofen | 3394 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | flurbiprofen | 3394 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | flurbiprofen | 3394 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | flurbiprofen | 3394 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | paromomycin | 5983 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | paromomycin | 5983 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | paromomycin | 5983 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | paromomycin | 5983 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | paromomycin | 5983 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | paromomycin | 5983 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | paromomycin | 5983 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | paromomycin | 5983 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | paromomycin | 5983 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | paromomycin | 5983 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | scopolamine | 3646 | drug-path |